355 related articles for article (PubMed ID: 29361915)
1. Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: the first report.
Narumi Y; Yoshida R; Minami Y; Yamamoto Y; Takeguchi S; Kano K; Takahashi K; Saito T; Sawada J; Terui H; Katayama T; Sasaki T; Ohsaki Y
BMC Cancer; 2018 Jan; 18(1):95. PubMed ID: 29361915
[TBL] [Abstract][Full Text] [Related]
2. Aquaporin-4 antibody positive neuromyelitis optica spectrum disorder associated with esophageal cancer.
Kon T; Ueno T; Suzuki C; Nunomura J; Igarashi S; Sato T; Tomiyama M
J Neuroimmunol; 2017 Aug; 309():38-40. PubMed ID: 28601284
[TBL] [Abstract][Full Text] [Related]
3. Bilateral oculomotor nerve palsy in a case of anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Yasuda K; Maki T; Takata M; Kimura K; Takahashi T; Kanbayashi T; Murase N; Ohtani R; Takahashi R; Nakamura M
J Clin Neurosci; 2019 Aug; 66():271-272. PubMed ID: 31178306
[TBL] [Abstract][Full Text] [Related]
4. A case report of neuromyelitis optica spectrum disorder induced by pembrolizumab treatment for lung adenocarcinoma: a clinical and immunohistochemical study.
Hirano S; Kojima A; Nakayama Y; Takeda T; Kishimoto T; Takahashi T; Kuwabara S; Mori M
BMC Neurol; 2022 Dec; 22(1):483. PubMed ID: 36517738
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic neuromyelitis optica spectrum disorder: A case report and review of the literature.
Annus Á; Bencsik K; Obál I; Kincses ZT; Tiszlavicz L; Höftberger R; Vécsei L
J Clin Neurosci; 2018 Feb; 48():7-10. PubMed ID: 29133107
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
[TBL] [Abstract][Full Text] [Related]
7. Pontine hemorrhage accompanied by neuromyelitis optica spectrum disorder.
Kamo H; Ueno Y; Sugiyama M; Miyamoto N; Yamashiro K; Tanaka R; Yokoyama K; Hattori N
J Neuroimmunol; 2019 May; 330():19-22. PubMed ID: 30769213
[TBL] [Abstract][Full Text] [Related]
8. Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level.
Nishimura H; Enokida H; Sakamoto T; Takahashi T; Hayami H; Nakagawa M
J Artif Organs; 2018 Sep; 21(3):378-382. PubMed ID: 29675599
[TBL] [Abstract][Full Text] [Related]
9. Aquaporin-4 antibody positive neuromyelitis optica spectrum disorder subsequent to rhabdomyolysis: a case report and literature review.
Shang K; Qin C; Bu BT; Tian DS
Int J Neurosci; 2019 Sep; 129(9):930-932. PubMed ID: 30722721
[TBL] [Abstract][Full Text] [Related]
10. Neuromyelitis optica spectrum disorder after treatment with pembrolizumab.
Shimada T; Hoshino Y; Tsunemi T; Hattori A; Nakagawa E; Yokoyama K; Hattori N
Mult Scler Relat Disord; 2020 Jan; 37():101447. PubMed ID: 31655267
[TBL] [Abstract][Full Text] [Related]
11. Gaze palsy, hypogeusia and a probable association with miscarriage of pregnancy--the expanding clinical spectrum of non-opticospinal neuromyelitis optica spectrum disorders: a case report.
Chang T; Withana M
BMC Res Notes; 2015 Feb; 8():36. PubMed ID: 25888897
[TBL] [Abstract][Full Text] [Related]
12. Two Cases of Pediatric AQP4-Antibody Positive Neuromyelitis Optica Spectrum Disorder Successfully Treated with Tocilizumab.
Breu M; Glatter S; Höftberger R; Freilinger M; Kircher K; Kasprian G; Seidl R; Kornek B
Neuropediatrics; 2019 Jun; 50(3):193-196. PubMed ID: 30913570
[TBL] [Abstract][Full Text] [Related]
13. Neuromyelitis optica spectrum disorder mimicking multiple sclerosis.
van Rooij LC; Wattjes MP; de Jong BA; van Oosten BW
Mult Scler Relat Disord; 2017 Oct; 17():54-56. PubMed ID: 29055475
[TBL] [Abstract][Full Text] [Related]
14. Transient Pulmonary Interstitial Lesions in Aquaporin-4-positive Neuromyelitis Optica Spectrum Disorder.
Asato Y; Kamitani T; Ootsuka K; Kuramochi M; Nakanishi K; Shimada T; Takahashi T; Misu T; Aoki M; Fujihara K; Kawabata Y
Intern Med; 2018 Oct; 57(20):2981-2986. PubMed ID: 29780127
[TBL] [Abstract][Full Text] [Related]
15. [The clinical analyses of neuromyelitis optica spectrum disorder initially presenting with area postrema syndrome in 14 patients].
Guo QF; Song DD; Wang QQ; Wang ZW; Liu JG; Qi XK
Zhonghua Nei Ke Za Zhi; 2017 May; 56(5):358-362. PubMed ID: 28460507
[No Abstract] [Full Text] [Related]
16. Frequency of brain MRI abnormalities in neuromyelitis optica spectrum disorder at presentation: A cohort of Latin American patients.
Carnero Contentti E; Daccach Marques V; Soto de Castillo I; Tkachuk V; Antunes Barreira A; Armas E; Chiganer E; de Aquino Cruz C; Di Pace JL; Hryb JP; Lavigne Moreira C; Lessa C; Molina O; Perassolo M; Soto A; Caride A
Mult Scler Relat Disord; 2018 Jan; 19():73-78. PubMed ID: 29156226
[TBL] [Abstract][Full Text] [Related]
17. Reduced sarcolemmal aquaporin 4 expression can support the differential diagnosis of neuromyelitis optica spectrum disorders.
Zhang W; Dong M; Dong H; Wang W; Sun W; Hao Y; Jiao Y; Cui L; Jiao J
J Neuroimmunol; 2020 Feb; 339():577121. PubMed ID: 31786498
[TBL] [Abstract][Full Text] [Related]
18. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
19. Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: A multicenter cohort study.
Kessler RA; Mealy MA; Jimenez-Arango JA; Quan C; Paul F; López R; Hopkins S; Levy M
Mult Scler Relat Disord; 2017 Oct; 17():198-201. PubMed ID: 29055457
[TBL] [Abstract][Full Text] [Related]
20. Lesions of the posterior limb of the internal capsule in neuromyelitis optica spectrum disorder.
Long Y; Wu L; Zhong R; Ouyang X; Liang J; Gao C; Chen X; Qiu W; Chang Y; Wang Z; Ye J
Neurol Res; 2017 May; 39(5):448-452. PubMed ID: 28262035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
